Product Information
ATORVASTATIN 20 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0285 per EA under NDC 16571013750. Its NADAC has been published 122 times since Feb 28, 2024.
Strength
20 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571013750
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209912On Market Since
10/20/2023
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 20 MG TABLET has been published 122 times since Feb 28, 2024, and over the history we have for it it has declined 30.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0285 per EA |
|---|---|
| All-time high | $0.0411 (Mar 13, 2024) |
| All-time low | $0.0277 (Nov 20, 2024) |
| 52-week high | $0.0354 |
| 52-week low | $0.0285 |
| Median price | $0.0336 |
| Average price | $0.0332 |
| Largest weekly change | +32.4% (Aug 21, 2024) |
| Weeks tracked | 122 |
| Tracking since | Feb 28, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0285 per EA (NDC 16571013750), effective Jun 24, 2026.
How has the price of ATORVASTATIN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 30.7%. It has been tracked across 122 weekly CMS publications since Feb 28, 2024.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?
Since Feb 28, 2024, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0277 (Nov 20, 2024) to a high of $0.0411 (Mar 13, 2024), with a median of $0.0336 per EA.
Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ATORVASTATIN 20 MG TABLET, but none are currently priced below it.
Who manufactures ATORVASTATIN 20 MG TABLET?
ATORVASTATIN 20 MG TABLET (NDC 16571013750) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification